Literature DB >> 7756613

T3 affects cerebellar astrocyte proliferation, GFAP and fibronectin organization.

A G Trentin1, V Moura Neto.   

Abstract

Thyroid hormone T3 and conditioned medium from cerebellar T3-treated astrocytes induced proliferation in astroglial cells. In addition, T3 treatment promoted alterations in the organization of cytoskeleton (GFAP) and extracellular matrix (fibronectin) in these cerebellar astrocytes in culture. GFAP filaments that normally spread in the cytoplasm of astrocytes became organized around the cell nucleus. Fibronectin that had a punctate distribution on control cell surface, became diffused in T3-treated astrocytes. This hormone also induced growth factor(s) secretion by astrocytes. These results suggest that T3 may be an important regulator of astrocyte growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756613     DOI: 10.1097/00001756-199501000-00017

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  Thyroid hormone acting on astrocytes in culture.

Authors:  A G Trentin; F C Gomes; F R Lima; V M Neto
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

Review 2.  The Role of Astrocytes in the Development of the Cerebellum.

Authors:  Ana Paula Bergamo Araujo; Raul Carpi-Santos; Flávia Carvalho Alcantara Gomes
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

3.  An exploratory study of the association between thyroid hormone and survival of amyotrophic lateral sclerosis.

Authors:  Zhenzhen Zheng; Xiaoyan Guo; Rui Huang; Xueping Chen; Huifang Shang
Journal:  Neurol Sci       Date:  2014-02-07       Impact factor: 3.307

4.  The reciprocal interactions between astrocytes and prostate cancer cells represent an early event associated with brain metastasis.

Authors:  Eliane Gouvêa de Oliveira Barros; Antonio Palumbo; Pedro Lucas Prado Mello; Rômulo Medina de Mattos; Julianna Henriques da Silva; Bruno Pontes; Nathan Bessa Viana; Rackele Ferreira do Amaral; Flavia Regina Souza Lima; Nathalia Meireles da Costa; Celia Yelimar Palmero; Leandro Miranda-Alves; Christina Maeda Takiya; Luiz Eurico Nasciutti
Journal:  Clin Exp Metastasis       Date:  2014-02-01       Impact factor: 5.150

5.  Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression.

Authors:  V Menet; M Giménez y Ribotta; N Chauvet; M J Drian; J Lannoy; E Colucci-Guyon; A Privat
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 6.  Thyroid hormone actions on neural cells.

Authors:  Sandra König; Vivaldo Moura Neto
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

7.  Changes in thyroid hormone receptors after permanent cerebral ischemia in male rats.

Authors:  Athanasios Lourbopoulos; Iordanis Mourouzis; Theodoros Karapanayiotides; Evangelia Nousiopoulou; Stavros Chatzigeorgiou; Theodoros Mavridis; Ioannis Kokkinakis; Olga Touloumi; Theano Irinopoulou; Konstantinos Chouliaras; Constantinos Pantos; Dimitris Karacostas; Nikolaos Grigoriadis
Journal:  J Mol Neurosci       Date:  2014-02-28       Impact factor: 3.444

8.  Thyroid hormone (T3)-induced up-regulation of voltage-activated sodium current in cultured postnatal hippocampal neurons requires secretion of soluble factors from glial cells.

Authors:  Vanessa Niederkinkhaus; Romy Marx; Gerd Hoffmann; Irmgard D Dietzel
Journal:  Mol Endocrinol       Date:  2009-05-21

9.  Thyroid hormone and the neuroglia: both source and target.

Authors:  Petra Mohácsik; Anikó Zeöld; Antonio C Bianco; Balázs Gereben
Journal:  J Thyroid Res       Date:  2011-08-23

10.  Glycosaminoglycans modulate C6 glioma cell adhesion to extracellular matrix components and alter cell proliferation and cell migration.

Authors:  Claudia Beatriz Nedel Mendes de Aguiar; Bruno Lobão-Soares; Marcio Alvarez-Silva; Andréa Gonçalves Trentin
Journal:  BMC Cell Biol       Date:  2005-08-19       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.